BRCA2 and breast cancer: The risk of contralateral breast cancer was estimated for patient subgroups defined by age group (Figure 1), gene (BRCA1 vs BRCA2), number of affected first-degree relatives, and by treatment received (surgery, chemotherapy, tamoxifen, radiotherapy, and ovarian ablation).